Holocene Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Holocene Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$168M	Buy	341,267 +124,766	+58%	+$67.7M	0.4%	67
2025 Q4	$125M	Buy	216,501 +120,209	+125%	+$68M	0.26%	106
2025 Q3	$46.7M	Buy	+96,292	New	+$44.8M	0.11%	188
2024 Q4	–	Sell	-214,959	Closed	-$133M	–	886
2024 Q3	$133M	Buy	214,959 +73,324	+52%	+$43.4M	0.54%	53
2024 Q2	$78.3M	Buy	141,635 +60,447	+74%	+$34.6M	0.33%	94
2024 Q1	$47.2M	Sell	81,188 -210,764	-72%	-$118M	0.17%	156
2023 Q4	$155M	Buy	+291,952	New	+$141M	0.6%	52
2023 Q2	–	Sell	-9,681	Closed	-$5.58M	–	864
2023 Q1	$5.58M	Buy	+9,681	New	+$5.46M	0.03%	288
2022 Q3	–	Sell	-666	Closed	-$362K	–	951
2022 Q2	$362K	Hold	666	–	–	﹤0.01%	734
2022 Q1	$393K	Sell	666 -668	-50%	-$384K	﹤0.01%	782
2021 Q4	$890K	Hold	1,334	–	–	﹤0.01%	694
2021 Q3	$762K	Buy	1,334 +371	+39%	+$204K	﹤0.01%	715
2021 Q2	$486K	Buy	+963	New	+$454K	﹤0.01%	748

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors's TMO Position: Q1 2026 in Review

Holocene Advisors increased its Thermo Fisher Scientific (TMO) stake by 58% in Q1 2026, buying an estimated $67.7M and bringing the position to 341,267 shares worth $168M. The position accounts for 0.4% of the portfolio, ranked #67.

Holocene Advisors first reported a position in TMO in Q2 2021 and has held it in 13 quarters since. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Holocene Advisors held 341,267 shares of Thermo Fisher Scientific worth $168M as of Q1 2026.
Holocene Advisors bought 124,766 Thermo Fisher Scientific shares in Q1 2026, an estimated $67.7M.
Thermo Fisher Scientific made up 0.4% of Holocene Advisors's portfolio in Q1 2026, its #67 holding.
Holocene Advisors first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 13 quarters since.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.